BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34610858)

  • 1. Effect of kisspeptin-54 on ovarian levels of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in an experimental model of ovarian hyperstimulation syndrome (OHSS).
    Birinci H; Vatansever HS; Yüncü M
    Reprod Fertil Dev; 2021 Nov; 33(16):799-809. PubMed ID: 34610858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice.
    Chuderland D; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Ron-El R; Shalgi R
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E258-66. PubMed ID: 23295464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dual Role of PEDF in the Pathogenesis of OHSS: Negating Both Angiogenic and Inflammatory Pathways.
    Miller I; Chuderland D; Grossman H; Ron-El R; Ben-Ami I; Shalgi R
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4699-4709. PubMed ID: 27680872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
    Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic vitamin D supplementation in ovarian hyperstimulation syndrome: an animal study.
    Turan GA; Eskicioglu F; Sivrikoz ON; Cengiz H; Gur EB; Tatar S; Sahin N; Yilmaz O
    Arch Gynecol Obstet; 2015 Aug; 292(2):421-7. PubMed ID: 25618750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.
    Şahin N; Apaydın N; Töz E; Sivrikoz ON; Genç M; Turan GA; Cengiz H; Eskicioğlu F
    Arch Gynecol Obstet; 2016 May; 293(5):1101-6. PubMed ID: 26690356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion.
    Zhai J; Liu J; Zhao S; Zhao H; Chen ZJ; Du Y; Li W
    Reproduction; 2017 Oct; 154(4):355-362. PubMed ID: 28676533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigment epithelium-derived factor (PEDF) negates hyperandrogenic PCOS features.
    Miller I; Bar-Joseph H; Nemerovsky L; Ben-Ami I; Shalgi R
    J Endocrinol; 2020 May; 245(2):291-300. PubMed ID: 32171180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists.
    Ferrero H; García-Pascual CM; Gaytán M; Morales C; Simón C; Gaytán F; Pellicer A; Gómez R
    Fertil Steril; 2014 Nov; 102(5):1468-1476.e1. PubMed ID: 25217874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle.
    Haas J; Bassil R; Gonen N; Meriano J; Jurisicova A; Casper RF
    Reprod Biol Endocrinol; 2018 May; 16(1):54. PubMed ID: 29843716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study.
    Turan GA; Eskicioglu F; Sivrikoz ON; Cengiz H; Adakan S; Gur EB; Tatar S; Sahin N; Yilmaz O
    Arch Gynecol Obstet; 2015 Nov; 292(5):1163-71. PubMed ID: 25990477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment epithelium-derived factor regulation by human chorionic gonadotropin in granulosa cells.
    Bar-Joseph H; Ben-Ami I; Ron-El R; Shalgi R; Chuderland D
    Reproduction; 2016 Feb; 151(2):179-85. PubMed ID: 26612427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.
    Quintana R; Kopcow L; Marconi G; Young E; Yovanovich C; Paz DA
    Fertil Steril; 2008 Oct; 90(4 Suppl):1511-6. PubMed ID: 18166186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model.
    Hortu I; Karadadas E; Ozceltik G; Tavmergen E; Tavmergen Goker EN; Yigitturk G; Erbas O
    Arch Gynecol Obstet; 2021 Apr; 303(4):1099-1108. PubMed ID: 33140116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.
    Akman L; Sahin G; Erbas O; Aktug H; Akdogan A; Goker EN; Taskiran D; Tavmergen E
    Gynecol Endocrinol; 2015 May; 31(5):369-73. PubMed ID: 25599748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome.
    Di Pietro M; Pascuali N; Scotti L; Irusta G; Bas D; May M; Tesone M; Abramovich D; Parborell F
    Mol Hum Reprod; 2017 Jun; 23(6):417-427. PubMed ID: 28379469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the Risk of OHSS by GnRH Agonist Triggering.
    Casper RF
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4396-8. PubMed ID: 26513003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent expression of PEDF and VEGF in blood serum and retina of rats with oxygen-induced retinopathy.
    Lei CT; Wu XL; Peng J; Chen XF; Qiao LF; Fan YC; Hu JB
    J Huazhong Univ Sci Technolog Med Sci; 2015 Feb; 35(1):135-139. PubMed ID: 25673207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome.
    Scotti L; Abramovich D; Pascuali N; Irusta G; Meresman G; Tesone M; Parborell F
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():392-401. PubMed ID: 25151950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.